James M. Strickland, Director at IMARX THERAPEUTICS INC (IMRX), bought 2,000 shares at $5.00 ($10K) on 2007-07-26, disclosed to the SEC on 2007-07-30.
Open-market purchase of $10k IMRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.